RDY
Dr Reddys Laboratories Ltd Health Care Pharmaceutical Preparations Russell 3000
$14.17Close
$11.30 – $15.2752-week range
Highlights
Cautions
- Not in an uptrend 3 of 8 trend conditions
- Extended 6.3 ATR above its 50-day average
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Trade setup
ATR%
2.1%
$0.29 a day · 2×ATR $13.58
RS
63 / 99
vs the universe
Trend
3 / 8
trend template
Relative volume
0.6×
vs 50-day average
Up/down volume
1.21
50 sessions
Implied move
—
no scheduled report
Trend template · 3 of 8
- Price above the 150 and 200-day averages: passes
- 150-day average above the 200-day: fails
- 200-day average rising for a month: fails
- 50-day average above the 150 and 200-day: fails
- Price above the 50-day average: passes
- At least 30% above the 52-week low: fails
- Within 25% of the 52-week high: passes
- RS rank 70 or higher: fails
Screen verdict
Not scorable — no classified balance sheet.
Last reported
Oct 29, 2026
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| May 29, 2026 | Annual ↗ | — | 0d |
| Jun 6, 2025 | Annual ↗ | — | 0d |
| Jun 12, 2024 | Annual ↗ | — | 0d |
| Jun 13, 2023 | Annual ↗ | — | 0d |
| Jun 27, 2022 | Annual ↗ | — | 0d |
| Jun 30, 2021 | Annual ↗ | — | 0d |
| Jun 15, 2020 | Annual ↗ | — | 0d |
| Jun 3, 2019 | Annual ↗ | — | 0d |
| Jul 12, 2018 | Annual ↗ | — | 0d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 29, 2026 | Foreign issuer report ↗ |
| Oct 29, 2026 | Foreign issuer report ↗ |
| Oct 26, 2026 | Foreign issuer report ↗ |
| Oct 26, 2026 | Foreign issuer report ↗ |
| Oct 23, 2026 | Foreign issuer report ↗ |
| Oct 23, 2026 | Foreign issuer report ↗ |
| Oct 23, 2026 | Foreign issuer report ↗ |
| Oct 23, 2026 | Foreign issuer report ↗ |
| Oct 21, 2026 | Foreign issuer report ↗ |
| Oct 14, 2026 | Foreign issuer report ↗ |
| Oct 8, 2026 | Foreign issuer report ↗ |
| Oct 7, 2026 | Foreign issuer report ↗ |